Research ArticleNeurology
Correlations of 18F-THK5351 PET with Postmortem Burden of Tau and Astrogliosis in Alzheimer Disease
Ryuichi Harada, Aiko Ishiki, Hideaki Kai, Naomi Sato, Katsutoshi Furukawa, Shozo Furumoto, Tetsuro Tago, Naoki Tomita, Shoichi Watanuki, Kotaro Hiraoka, Yoichi Ishikawa, Yoshihito Funaki, Tadaho Nakamura, Takeo Yoshikawa, Ren Iwata, Manabu Tashiro, Hironobu Sasano, Tetsuyuki Kitamoto, Kazuhiko Yanai, Hiroyuki Arai, Yukitsuka Kudo and Nobuyuki Okamura
Journal of Nuclear Medicine April 2018, 59 (4) 671-674; DOI: https://doi.org/10.2967/jnumed.117.197426
Ryuichi Harada
1Department of Pharmacology, Tohoku University School of Medicine, Sendai, Japan
2Department of Gerontology and Geriatrics, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan
Aiko Ishiki
2Department of Gerontology and Geriatrics, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan
Hideaki Kai
3Department of Neurological Science, Tohoku University School of Medicine, Sendai, Japan
Naomi Sato
4Department of Pathology, Tohoku University School of Medicine, Sendai, Japan
Katsutoshi Furukawa
2Department of Gerontology and Geriatrics, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan
5Division of Community Medicine, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan
Shozo Furumoto
6Cyclotron and Radioisotope Center, Tohoku University, Sendai, Japan
Tetsuro Tago
7Research Team for Neuroimaging, Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan; and
Naoki Tomita
2Department of Gerontology and Geriatrics, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan
Shoichi Watanuki
6Cyclotron and Radioisotope Center, Tohoku University, Sendai, Japan
Kotaro Hiraoka
6Cyclotron and Radioisotope Center, Tohoku University, Sendai, Japan
Yoichi Ishikawa
6Cyclotron and Radioisotope Center, Tohoku University, Sendai, Japan
Yoshihito Funaki
6Cyclotron and Radioisotope Center, Tohoku University, Sendai, Japan
Tadaho Nakamura
8Division of Pharmacology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan
Takeo Yoshikawa
1Department of Pharmacology, Tohoku University School of Medicine, Sendai, Japan
Ren Iwata
6Cyclotron and Radioisotope Center, Tohoku University, Sendai, Japan
Manabu Tashiro
6Cyclotron and Radioisotope Center, Tohoku University, Sendai, Japan
Hironobu Sasano
4Department of Pathology, Tohoku University School of Medicine, Sendai, Japan
Tetsuyuki Kitamoto
3Department of Neurological Science, Tohoku University School of Medicine, Sendai, Japan
Kazuhiko Yanai
1Department of Pharmacology, Tohoku University School of Medicine, Sendai, Japan
6Cyclotron and Radioisotope Center, Tohoku University, Sendai, Japan
Hiroyuki Arai
2Department of Gerontology and Geriatrics, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan
Yukitsuka Kudo
2Department of Gerontology and Geriatrics, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan
Nobuyuki Okamura
6Cyclotron and Radioisotope Center, Tohoku University, Sendai, Japan
8Division of Pharmacology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 59, Issue 4
April 1, 2018
Correlations of 18F-THK5351 PET with Postmortem Burden of Tau and Astrogliosis in Alzheimer Disease
Ryuichi Harada, Aiko Ishiki, Hideaki Kai, Naomi Sato, Katsutoshi Furukawa, Shozo Furumoto, Tetsuro Tago, Naoki Tomita, Shoichi Watanuki, Kotaro Hiraoka, Yoichi Ishikawa, Yoshihito Funaki, Tadaho Nakamura, Takeo Yoshikawa, Ren Iwata, Manabu Tashiro, Hironobu Sasano, Tetsuyuki Kitamoto, Kazuhiko Yanai, Hiroyuki Arai, Yukitsuka Kudo, Nobuyuki Okamura
Journal of Nuclear Medicine Apr 2018, 59 (4) 671-674; DOI: 10.2967/jnumed.117.197426
Correlations of 18F-THK5351 PET with Postmortem Burden of Tau and Astrogliosis in Alzheimer Disease
Ryuichi Harada, Aiko Ishiki, Hideaki Kai, Naomi Sato, Katsutoshi Furukawa, Shozo Furumoto, Tetsuro Tago, Naoki Tomita, Shoichi Watanuki, Kotaro Hiraoka, Yoichi Ishikawa, Yoshihito Funaki, Tadaho Nakamura, Takeo Yoshikawa, Ren Iwata, Manabu Tashiro, Hironobu Sasano, Tetsuyuki Kitamoto, Kazuhiko Yanai, Hiroyuki Arai, Yukitsuka Kudo, Nobuyuki Okamura
Journal of Nuclear Medicine Apr 2018, 59 (4) 671-674; DOI: 10.2967/jnumed.117.197426
Jump to section
Related Articles
Cited By...
- Preclinical Characterization of the Tau PET Tracer [18F]SNFT-1: Comparison of Tau PET Tracers
- Preclinical Characterization of the Tau PET Tracer [18F]SNFT-1: Comparison of Tau PET Tracers
- First-in-Humans Evaluation of 18F-SMBT-1, a Novel 18F-Labeled Monoamine Oxidase-B PET Tracer for Imaging Reactive Astrogliosis
- Patterns of Distribution of 18F-THK5351 Positron Emission Tomography in Alzheimers Disease Continuum
- Occipital Tau Deposition and Astrogliosis After Traumatic Brain Injuries in a Kendo Player
- 18F-SMBT-1: A Selective and Reversible PET Tracer for Monoamine Oxidase-B Imaging
- In vivo visualization of propagating {alpha}-synuclein pathologies in mouse and marmoset models by a bimodal imaging probe, C05-05
- Data-driven approaches for Tau-PET imaging biomarkers in Alzheimers disease
- Biomarkers for the diagnosis of Alzheimers disease, dementia Lewy body, frontotemporal dementia and vascular dementia
- Characterization of 3 Novel Tau Radiopharmaceuticals, 11C-RO-963, 11C-RO-643, and 18F-RO-948, in Healthy Controls and in Alzheimer Subjects